MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


0026-895X/04/6501-196-206$20.00
Mol Pharmacol 65:196-206, 2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tran, T. M.
Right arrow Articles by Clark, R. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tran, T. M.
Right arrow Articles by Clark, R. B.

Characterization of Agonist Stimulation of cAMP-Dependent Protein Kinase and G Protein-Coupled Receptor Kinase Phosphorylation of the {beta}2-Adrenergic Receptor Using Phosphoserine-Specific Antibodies

Tuan M. Tran, Jackie Friedman, Eyad Qunaibi, Faiza Baameur, Robert H. Moore, and Richard B. Clark

The University of Texas, Houston, Medical School, Houston, Texas (T.M.T., J.F., E.Q., F.B., R.B.C.); and Baylor College of Medicine and Texas Children's Hospital, Houston, Texas (R.H.M.)

Agonist-stimulated desensitization of the {beta}2-adrenergic receptor ({beta}2AR) is caused by both a potent cAMP-dependent protein kinase (PKA)-mediated phosphorylation and a less potent, occupancy-dependent, G protein-coupled receptor kinase (GRK)-mediated phosphorylation that leads to {beta}-arrestin binding and internalization. In this study the kinetics of phosphorylation of the third intracellular loop PKA site Ser262 and the putative C-tail GRK sites Ser355, Ser356 of the human {beta}2AR overexpressed in human embryonic kidney (HEK) 293 cells were characterized using phosphoserine-specific antibodies. Specificity of the antibodies was shown by their lack of reactivity with mutant {beta}2ARs lacking the respective sites. In addition, overexpression of GRK2 and GRK5 increased basal levels of phosphorylation of the GRK sites Ser355, Ser356 in both COS-7 and HEK 293 cells. Epinephrine, prostaglandin E1, and forskolin at maximum concentrations stimulated phosphorylation of the {beta}2AR PKA site (Ser262) by 4-fold, whereas PMA stimulated it by 2-fold. Epinephrine stimulated PKA site phosphorylation with an EC50 of 20 to 40 pM. In contrast, epinephrine stimulated GRK site phosphorylation (Ser355,Ser356) with an EC50 of 200 nM (1-min treatments), which is more than 4000-fold higher relative to PKA site phosphorylation, consistent with an occupancy-driven process. After 10 to 30 min, the EC50 for epinephrine stimulation of GRK site phosphorylation was reduced to 10 to 20 nM but was still {approx}200-fold greater than for the PKA site. The EC50 for internalization correlated with GRK site phosphorylation and showed a similar shift with time of epinephrine stimulation. The kinetics of epinephrine-stimulated GRK site phosphorylation were not altered in a mutant of the {beta}2AR lacking the PKA consensus sites. The initial levels (2 min) of a range of agonist-stimulated GRK site phosphorylations were correlated with their efficacy for activation of adenylyl cyclase, namely epinephrine >= formoterol = fenoterol > terbutaline = zinterol = albuterol > salmeterol >> dobutamine >= ephedrine. However, after 20 to 30 min of treatment, agonists with intermediate strengths, such as albuterol and salmeterol, stimulate GRK site phosphorylations that are approximately equal to that produced by epinephrine, and the correlation breaks down. The GRK and PKA site antibodies were also effective in detecting phosphorylation of the endogenous {beta}2AR expressed in A431 human epidermoid carcinoma cells. To summarize, our results show a remarkable amplification of PKA site phosphorylation relative to the putative GRK site phosphorylation, heterologous stimulation of the PKA site phosphorylation, no dependence of GRK site phosphorylation on PKA sites, and a reasonable correlation of initial levels of GRK site phosphorylation with the strength of a range of agonists.


Received June 5, 2003; accepted October 3, 2003

Address correspondence to: Dr. Richard B. Clark, Department of Integrative Biology and Pharmacology, The University of Texas, Houston, Medical School, P.O. Box 20708, Houston, TX 77225. E-mail: richard.b.clark{at}uth.tmc.edu




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
S. M. Pontier, Y. Percherancier, S. Galandrin, A. Breit, C. Gales, and M. Bouvier
Cholesterol-dependent Separation of the {beta}2-Adrenergic Receptor from Its Partners Determines Signaling Efficacy: INSIGHT INTO NANOSCALE ORGANIZATION OF SIGNAL TRANSDUCTION
J. Biol. Chem., September 5, 2008; 283(36): 24659 - 24672.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. D. Bruss, W. Richter, K. Horner, S.-L. C. Jin, and M. Conti
Critical Role of PDE4D in {beta}2-Adrenoceptor-dependent cAMP Signaling in Mouse Embryonic Fibroblasts
J. Biol. Chem., August 15, 2008; 283(33): 22430 - 22442.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
D. A. Deshpande, B. S. Theriot, R. B. Penn, and J. K. L. Walker
{beta}-Arrestins specifically constrain {beta}2-adrenergic receptor signaling and function in airway smooth muscle
FASEB J, July 1, 2008; 22(7): 2134 - 2141.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
G. S. Lynch and J. G. Ryall
Role of {beta}-Adrenoceptor Signaling in Skeletal Muscle: Implications for Muscle Wasting and Disease
Physiol Rev, April 1, 2008; 88(2): 729 - 767.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Physiol.Home page
W. Xin, T. M. Tran, W. Richter, R. B. Clark, and T. C. Rich
Roles of GRK and PDE4 Activities in the Regulation of {beta}2 Adrenergic Signaling
J. Gen. Physiol., March 31, 2008; 131(4): 349 - 364.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. T. Drake, J. D. Violin, E. J. Whalen, J. W. Wisler, S. K. Shenoy, and R. J. Lefkowitz
{beta}-Arrestin-biased Agonism at the {beta}2-Adrenergic Receptor
J. Biol. Chem., February 29, 2008; 283(9): 5669 - 5676.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. D. Violin, L. M. DiPilato, N. Yildirim, T. C. Elston, J. Zhang, and R. J. Lefkowitz
{beta}2-Adrenergic Receptor Signaling and Desensitization Elucidated by Quantitative Modeling of Real Time cAMP Dynamics
J. Biol. Chem., February 1, 2008; 283(5): 2949 - 2961.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
K. S. Murthy, S. Mahavadi, J. Huang, H. Zhou, and W. Sriwai
Phosphorylation of GRK2 by PKA augments GRK2-mediated phosphorylation, internalization, and desensitization of VPAC2 receptors in smooth muscle
Am J Physiol Cell Physiol, February 1, 2008; 294(2): C477 - C487.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Wang, V. De Arcangelis, X. Gao, B. Ramani, Y.-s. Jung, and Y. Xiang
Norepinephrine- and Epinephrine-induced Distinct 2-Adrenoceptor Signaling Is Dictated by GRK2 Phosphorylation in Cardiomyocytes
J. Biol. Chem., January 25, 2008; 283(4): 1799 - 1807.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Willoughby, G. S. Baillie, M. J. Lynch, A. Ciruela, M. D. Houslay, and D. M. F. Cooper
Dynamic Regulation, Desensitization, and Cross-talk in Discrete Subcellular Microdomains during beta2-Adrenoceptor and Prostanoid Receptor cAMP Signaling
J. Biol. Chem., November 23, 2007; 282(47): 34235 - 34249.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. W. Jones, G. J. Song, E. K. Greuber, and P. M. Hinkle
Phosphorylation of the Endogenous Thyrotropin-releasing Hormone Receptor in Pituitary GH3 Cells and Pituitary Tissue Revealed by Phosphosite-specific Antibodies
J. Biol. Chem., April 27, 2007; 282(17): 12893 - 12906.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
I. Torrecilla, E. J. Spragg, B. Poulin, P. J. McWilliams, S. C. Mistry, A. Blaukat, and A. B. Tobin
Phosphorylation and regulation of a G protein-coupled receptor by protein kinase CK2
J. Cell Biol., April 9, 2007; 177(1): 127 - 137.
[Abstract] [Full Text] [PDF]


Home page
J Biomol ScreenHome page
L. Elster, C. Elling, and A. Heding
Bioluminescence Resonance Energy Transfer as a Screening Assay: Focus on Partial and Inverse Agonism
J Biomol Screen, February 1, 2007; 12(1): 41 - 49.
[Abstract] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
R. H. Moore, E. E. Millman, V. Godines, N. A. Hanania, T. M. Tran, H. Peng, B. F. Dickey, B. J. Knoll, and R. B. Clark
Salmeterol Stimulation Dissociates beta2-Adrenergic Receptor Phosphorylation and Internalization
Am. J. Respir. Cell Mol. Biol., February 1, 2007; 36(2): 254 - 261.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. D. Urban, W. P. Clarke, M. von Zastrow, D. E. Nichols, B. Kobilka, H. Weinstein, J. A. Javitch, B. L. Roth, A. Christopoulos, P. M. Sexton, et al.
Functional Selectivity and Classical Concepts of Quantitative Pharmacology
J. Pharmacol. Exp. Ther., January 1, 2007; 320(1): 1 - 13.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
T. M. Tran, J. Friedman, F. Baameur, B. J. Knoll, R. H. Moore, and R. B. Clark
Characterization of beta2-Adrenergic Receptor Dephosphorylation: Comparison with the Rate of Resensitization
Mol. Pharmacol., January 1, 2007; 71(1): 47 - 60.
[Abstract] [Full Text] [PDF]


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
W. E. Schutzer, H. Xue, J. F. Reed, and S. L. Mader
Effect of Age on Vascular {beta}2-Adrenergic Receptor Desensitization Is Not Mediated by the Receptor Coupling to G{alpha}i Proteins.
J. Gerontol. A Biol. Sci. Med. Sci., September 1, 2006; 61(9): 899 - 906.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. D. Violin, X.-R. Ren, and R. J. Lefkowitz
G-protein-coupled Receptor Kinase Specificity for beta-Arrestin Recruitment to the beta2-Adrenergic Receptor Revealed by Fluorescence Resonance Energy Transfer
J. Biol. Chem., July 21, 2006; 281(29): 20577 - 20588.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
S. Glaser, D. Alvaro, H. Francis, Y. Ueno, L. Marucci, A. Benedetti, S. D. Morrow, M. Marzioni, M. G. Mancino, J. L. Phinizy, et al.
Adrenergic receptor agonists prevent bile duct injury induced by adrenergic denervation by increased cAMP levels and activation of Akt
Am J Physiol Gastrointest Liver Physiol, April 1, 2006; 290(4): G813 - G826.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. J. Vaughan, E. E. Millman, V. Godines, J. Friedman, T. M. Tran, W. Dai, B. J. Knoll, R. B. Clark, and R. H. Moore
Role of the G Protein-coupled Receptor Kinase Site Serine Cluster in beta2-Adrenergic Receptor Internalization, Desensitization, and beta-Arrestin Translocation
J. Biol. Chem., March 17, 2006; 281(11): 7684 - 7692.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. K. Shenoy, M. T. Drake, C. D. Nelson, D. A. Houtz, K. Xiao, S. Madabushi, E. Reiter, R. T. Premont, O. Lichtarge, and R. J. Lefkowitz
beta-Arrestin-dependent, G Protein-independent ERK1/2 Activation by the beta2 Adrenergic Receptor
J. Biol. Chem., January 13, 2006; 281(2): 1261 - 1273.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. Kageyama, K. Hanada, T. Moriyama, T. Nigawara, S. Sakihara, and T. Suda
G Protein-Coupled Receptor Kinase 2 Involvement in Desensitization of Corticotropin-Releasing Factor (CRF) Receptor Type 1 by CRF in Murine Corticotrophs
Endocrinology, January 1, 2006; 147(1): 441 - 450.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. W. Jones and P. M. Hinkle
{beta}-Arrestin Mediates Desensitization and Internalization but Does Not Affect Dephosphorylation of the Thyrotropin-releasing Hormone Receptor
J. Biol. Chem., November 18, 2005; 280(46): 38346 - 38354.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Namkung and D. R. Sibley
Protein Kinase C Mediates Phosphorylation, Desensitization, and Trafficking of the D2 Dopamine Receptor
J. Biol. Chem., November 19, 2004; 279(47): 49533 - 49541.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics